kiran mazumdar shaw

Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India; Find all the details here

By CNBC-TV18

Forbes India Rich List 2019: Mukesh Ambani tops for 12th year in a row

By CNBC-TV18

Corporate tax cut is a much needed reform, says Biocon's Kiran Mazumdar Shaw

Indian cancer patients may get access to CAR T-cell therapy in 8 months, says Dr Siddhartha Mukherjee

By Shereen Bhan

Expect to launch insulin glargine on time, says Biocon's Kiran Mazumdar Shaw

By Latha Venkatesh , Sonia Shenoy

Biocon’s biologics business is at an inflection point, says CMD Kiran Mazumdar Shaw

By Latha Venkatesh , Sonia Shenoy

more news

Temasek Holdings, True North-CPPIB look to buy stake in Biocon subsidiary, says report

By CNBC-TV18

Pfizer-Mylan deal will not impact Biocon's business, says CMD Kiran Mazumdar Shaw

By Sonia Shenoy , Latha Venkatesh

Live TV

kiran mazumdar shaw

Forbes India Rich List 2019: Mukesh Ambani tops for 12th year in a row

Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India; Find all the details here

Indian cancer patients may get access to CAR T-cell therapy in 8 months, says Dr Siddhartha Mukherjee

Expect to launch insulin glargine on time, says Biocon's Kiran Mazumdar Shaw

Biocon’s biologics business is at an inflection point, says CMD Kiran Mazumdar Shaw

Forbes India Rich List 2019: Mukesh Ambani tops for 12th year in a row

Corporate tax cut is a much needed reform, says Biocon's Kiran Mazumdar Shaw

Indian cancer patients may get access to CAR T-cell therapy in 8 months, says Dr Siddhartha Mukherjee

Expect to launch insulin glargine on time, says Biocon's Kiran Mazumdar Shaw

Biocon’s biologics business is at an inflection point, says CMD Kiran Mazumdar Shaw

Temasek Holdings, True North-CPPIB look to buy stake in Biocon subsidiary, says report

Biocon surges 5% after profit zooms 73% in June quarter

Biocon says USFDA observations largely procedural in nature

NBCC, Suraksha Realty may submit revised offers bids to acquire Jaypee Infratech

Nirmala Sitharaman on telecom sector stress: Don't want any company to shut operations

Pfizer-Mylan deal will not impact Biocon's business, says CMD Kiran Mazumdar Shaw

Biocon says growth momentum to continue in Q2, Trastuzumab launch in focus

Biocon stock hovers around 52-week low as its Malyasian facility undergoes inspection

Modi government planning to introduce 'One Nation, One Pay Day' to protect working-class

Finance minister Nirmala Sitharaman meets GST stakeholders, discuss user-friendly filling process